RecruitingNCT06925269

DMD Voice: Qualitative Interviews With Patients and Caregivers

Duchenne Muscular Dystrophy Quality of Life: Qualitative Interviews With Patients and Caregivers


Sponsor

Red Nucleus Enterprise Solutions, LLC

Enrollment

68 participants

Start Date

Mar 31, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to understand DMD functional losses or abilities and their association with independence and quality of life from the perspective of individuals with DMD and/or and their caregivers. This is a qualitative interview study in which individuals with DMD and/or their caregivers will be asked to participate in a semi-structured, approximately 60- minute interview. Interviews will focus on functional abilities and independence. Caregivers and boys with DMD will be interviewed. This study includes no treatment nor intervention; however, some participants are being treated by a drug that is approved in the U.S. and the U.K. and under investigation in other geographies.


Eligibility

Sex: MALEMin Age: 10 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with duchenne muscular dystrophy (dmd). The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Red Nucleus

Yardley, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06925269


Related Trials